Skip to main content
Fig. 6 | Lipids in Health and Disease

Fig. 6

From: Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells

Fig. 6

LDL dampens the efficacy of anlotinib. A Anlotinib alone or in combination with LDL (50 g/ml) was applied to A549 and H460 cells for 72 h. Viability was evaluated using metabolic MTT assay. B Wound-healing assay of H460 cells treated with anlotinib, LDL or both and their respective quantitative histograms. C Intracellular TC level in anlotinib treated cells. *P < 0.05; **P < 0.01 by Student’s t test

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X